Bokf Na Lowers Stock Position in Healthpeak Properties, Inc. $DOC

Bokf Na lessened its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 40.6% during the 4th quarter, Holdings Channel.com reports. The firm owned 84,393 shares of the real estate investment trust’s stock after selling 57,585 shares during the quarter. Bokf Na’s holdings in Healthpeak Properties were worth $1,357,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the company. State Street Corp increased its holdings in shares of Healthpeak Properties by 1.8% during the 3rd quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock valued at $947,889,000 after purchasing an additional 895,460 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Healthpeak Properties by 41.0% in the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after buying an additional 8,212,504 shares in the last quarter. Cullen Capital Management LLC increased its holdings in Healthpeak Properties by 6.7% in the third quarter. Cullen Capital Management LLC now owns 10,232,875 shares of the real estate investment trust’s stock valued at $195,960,000 after buying an additional 641,771 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Healthpeak Properties by 4.1% in the third quarter. Dimensional Fund Advisors LP now owns 10,228,560 shares of the real estate investment trust’s stock worth $195,873,000 after acquiring an additional 400,900 shares during the period. Finally, Bank of America Corp DE boosted its stake in shares of Healthpeak Properties by 28.5% during the 3rd quarter. Bank of America Corp DE now owns 9,936,934 shares of the real estate investment trust’s stock worth $190,292,000 after acquiring an additional 2,206,222 shares in the last quarter. 93.57% of the stock is owned by institutional investors and hedge funds.

Healthpeak Properties Price Performance

Healthpeak Properties stock opened at $19.61 on Friday. The stock has a market cap of $13.52 billion, a P/E ratio of 61.28, a price-to-earnings-growth ratio of 2.72 and a beta of 1.00. The company has a current ratio of 2.96, a quick ratio of 2.82 and a debt-to-equity ratio of 1.15. Healthpeak Properties, Inc. has a 12-month low of $15.70 and a 12-month high of $19.87. The company has a fifty day simple moving average of $17.02 and a 200-day simple moving average of $17.16.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The firm had revenue of $752.95 million for the quarter, compared to the consensus estimate of $694.59 million. During the same quarter last year, the business posted $0.46 EPS. The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Equities analysts expect that Healthpeak Properties, Inc. will post 1.74 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be issued a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 6.2%. The ex-dividend date is Monday, June 15th. Healthpeak Properties’s dividend payout ratio (DPR) is 381.25%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on DOC shares. Citigroup dropped their target price on Healthpeak Properties from $18.00 to $17.50 and set a “neutral” rating on the stock in a research report on Wednesday, April 1st. Wells Fargo & Company reiterated a “positive” rating on shares of Healthpeak Properties in a research report on Tuesday, February 3rd. Scotiabank raised Healthpeak Properties to a “hold” rating in a report on Thursday, April 23rd. Weiss Ratings restated a “hold (c-)” rating on shares of Healthpeak Properties in a research report on Friday, April 24th. Finally, Morgan Stanley reduced their target price on Healthpeak Properties from $21.00 to $18.00 and set an “overweight” rating for the company in a research note on Tuesday, April 28th. Five research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $18.04.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.